FERMALAC ECC 1B DIN 00351547
Health Canada record
| Active ingredient(s) | LACTOBACILLUS RHAMNOSUS 0.7 B; LACTOBACILLUS BULGARICUS 0.15 B; STREPTOCOCCUS THERMOPHILUS 0.15 B |
|---|---|
| Dosage form | Capsule (Enteric-Coated) |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | A07FA01 LACTIC ACID PRODUCING ORGANISMS |
| Original market date | 31-Dec-1960 |
| Current status date | 08-Sep-2009 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LACTOBACILLUS RHAMNOSUS
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02232997 | INTESTALIFE | HOLISTA HEALTH (CANADA) INC. | Capsule | LACTOBACILLUS RHAMNOSUS 3.4 B; LACTOBACILLUS ACIDOPHILUS 0.4 B; BIFIDOBACTERIUM LONGUM 0.2 B | Cancelled Post Market |